Four MUST-OWN
‘Alpha Gene’
stocks for your
portfolio in 2025…
Dear Reader,
In life, genetics govern everything.
Some people’s genes even give them almost superhuman advantages.
For example, Usain Bolt has what’s called the ‘sprinter gene’…
It’s what allows him to run 100 metres in a lightning-fast 9.58 seconds.
British strongman Eddie Hall has the ‘Hercules gene’…
It’s a big reason why he was the first person in the world to lift 500kg off the floor.
And Einstein’s genetics gave him a bigger prefrontal cortex, which helped him become the world’s most famous physicist.
And it turns out…
A similar thing is true in the stock market.
Because over the past 10 years, some stocks have demonstrated a ‘genetic’ advantage that has allowed them to grow, on average, SIX times faster than the wider Aussie market.
Callum Newman
Hello, my name is Callum Newman.
I’m a financial analyst who has spent the last 13 years specialising in a niche area of the ASX.
And what I’ve found could change how you look at investing forever.
Many companies with this ‘Alpha Gene’:
Investing in a small basket of these ‘Alpha Gene’ stocks over the last 10 years would have made you SIX times more money than just parking your money in the ASX 300 index.
And when you drill down on specific stocks, the numbers get even more impressive…
Take logistics technology firm WiseTech Global [ASX:WTC].
This ‘Alpha Gene’ stock is up an incredible 2,900% in under a decade…
Australia’s largest bathroom and plumbing supply business, Reece Limited [ASX:REH], is another example.
It’s up an astounding 4,600% since the early 2000s…
And Pro Medicus [ASX:PME], a leading provider of medical imaging services, is up an exceptional 22,000% since 2000…
Of course, not all ‘Alpha Gene’ stocks performed like these examples — and I don’t get all of my calls right either…
But this just shows you the potential of stocks with the ‘Alpha Gene’.
So, if you want to understand why some stocks appear to have an in-built performance advantage over others, keep watching.
Right now, they’re all still trading for under seven bucks per share…
But that might not be the case for much longer.
Now, I know what you might be thinking, but no…
You can forget about chasing cheap valuations…equity risk premia…technical analysis…
And all that macro stuff, like interest rates…bond yields…or whatever chaos Trump is inflicting on the economy right now…
Because I’ll be blunt…
I couldn’t care less about any of that.
My strategy is focused on finding undiscovered ‘Alpha Gene’ companies.
That’s it — that’s all I want to do.
Finding shares with this ‘genetic’ advantage…and potentially riding them higher.
Because over my 13-year career as a professional stock analyst, I’ve found that…
The simple fact is…
Companies with this trait just seem to do way better than companies without it.
It doesn’t matter what industry they’re in…
Or what market cap size they’ve got…
The thing that matters above and beyond everything else is the ‘Alpha Gene’.
I just mentioned how a basket of these stocks made SIX times more money than the ASX 300 over the last 10 years.
But let me put that in perspective for you…
That’s the difference between turning a modest $10,000 investment into $30,000…or $130,000.
And get this: the outperformance in my favourite part of the market — the Aussie small-cap sector — is even better…
Because from 2021 to 2024, a certain group of smaller ‘Alpha Gene’ companies returned NINE times more than the ASX Small Ordinaries index…
So, you’ve got to ask yourself…
Why ever settle for average gains in ANY market…
If you can make MANY TIMES MORE simply by investing in companies with the ‘Alpha Gene’?
Now, I’m not saying these stocks are guaranteed winners…
…but I am saying they give you the best chance at building a cracking portfolio that outperforms.
We’ll get to the specifics in a moment.
First, you need to understand that this correlation doesn’t just show up in Aussie shares…
This ‘gene’ is also present in some of the best-performing US stocks of all time, including…
In fact, ‘Alpha Gene’ stocks could have made you THREE times more money than the US S&P 500 index since 1990.
Again, I’m not saying all ‘Alpha Gene’ stocks performed like the examples I just showed you…but I hope they got your attention.
Look, people love to make the stock market way more complex than it needs to be.
But what I’m telling you here is as simple as it gets.
And I’m not the only one who thinks so…
Take Marc Andreessen, founder of a16z — one of the biggest venture capital firms on the planet.
Back in 2009, he and his co-founder wanted to understand what made some stocks go up more than others.
So, they dug through the top performing tech companies over the last 50 years and found an ‘overwhelming majority’ shared a common trait…
You guessed it: the ‘Alpha Gene’.
They used this knowledge to get in early on Facebook [NASDAQ:META], Airbnb [NASDAQ:ABNB], Instagram, Twitter, Coinbase [NASDAQ:COIN] — and many other companies that are now household names…
And grow their fund more than 13,000% in 16 years.
Then there’s Martin Sosnoff…
He’s had a successful 60-year career on Wall Street…
And his private fund is still outperforming the S&P 500 today.
There’s also my friend Chris Mayer, author of the best-selling book 100 Baggers.
It’s a guide for finding stocks that will make you 100 times your money.
Chris has spent countless hours digging through stock market history to identify five factors common to 100-bagger stocks…
One of them being — you guessed it — this ‘Alpha Gene’.
Today it’s my goal to help you take advantage of this phenomenon too, and to be clear…
The connection between stocks with the ‘Alpha Gene’ and massive outperformance is undeniable.
There are scores of examples of it playing out all over the world.
For example, retail brand management firm Premier Investments [ASX:PMV] has this ‘gene’.
Its stock is up over 1,000% since 2000.
Luxury furniture retailer Nick Scali [ASX:NCK] is another great example.
It’s also up over 1,000% since 2004.
Software services firm Objective Corporation [ASX:OCL] has this ‘Alpha Gene’ too…
It’s up over 1,500% since 2000.
Consumer homewares company Temple & Webster [ASX:TPW] is up over 1,600% since 2016.
ARB Corporation [ASX:ARB] is up over 3,200% since the early 2000s.
Resmed [ASX:RMD] — up over 3,800% since 2000.
And let’s not forget everyone’s favourite Aussie resource stock, Fortescue [ASX:FMG].
This legendary company has the ‘Alpha Gene’ as well…
That’s a big reason why it’s up more than 158,000% since the early 2000s.
Now, of course, not all ‘Alpha Gene’ stocks have performed like these…
And not all stocks with this ‘Alpha Gene’ go up…
Because there are no guarantees when it comes to the markets.
Not to mention, many of these companies start out as small-caps — one of the riskiest sectors on the ASX.
That means they have huge upside potential…but they can also nosedive if things don’t go as expected.
So, you should never invest more than you can afford to lose.
That said, the evidence I’ve been showing you today demonstrates the undeniable connection between the ‘Alpha Gene’ and massive long-term outperformance.
Best of all…
This strategy gives you the chance to multiply your money…
All four of these stocks have this ‘gene’.
All four are practically unknown — still trading for under seven bucks per share.
And all — I believe — have the potential to hand you impressive gains…
If we’re lucky, maybe even like the gains I’ve shown you today.
Again, I’m not saying these stocks are without risk…
Like all shares, they’re volatile — and you could lose money on them. That’s always a possibility.
However, if you’re a switched-on investor, I reckon these four stocks need to be on your radar for 2025.
Of course, there’s still one big question I need to answer…
Imagine two public companies:
Company A and Company B.
Company A is currently being run by a career CEO…
This guy has been parachuted in to get the share price firing.
The board of directors has enticed him with a big compensation package to achieve big results.
But the CEO takes his marching orders from the investment bankers and financial bean counters.
So, everything he does is focused on ‘beating’ the latest corporate earnings guidance.
In other words, Company A’s core mission is NOT this CEO’s life’s work…
In fact, it’s more likely that this gig is just another big pay day between rounds of golf with his buddies.
Then there’s Company B.
Company B is still run by its founder or key long-term shareholder…
For years, they’ve been pouring their blood, sweat and tears into bringing their vision to life…
Perhaps they mortgaged the family home to launch their business…
Or they walked away from a stable corporate salary to follow their dreams instead.
Most importantly, they hold fast to the core values that created the company in the first place…no matter what the corporate bean counters say.
They’re planning and strategising…
Not just for the next quarter…
But for the next DECADE.
That’s the mentality I’m talking about.
So, which company — or, more specifically, which type of leader — would you trust with your money?
I think the answer is obvious…
Companies that are run by their founder or key long-term shareholder…
Typically treat their company like a legacy rather than a job.
All the evidence I’ve shown you today suggests that companies run by people with ‘skin in the game’ tend to perform MUCH better than the rest of the pack.
People like this tend to build companies that are more innovative…
Generate revenue faster…
And — most importantly for us — they can often deliver bigger returns for their investors.
2023 was a rough year for the ASX…
Especially for the sector of the market I specialise in, Aussie small-cap stocks.
But despite all that chaos…
I sent a message to subscribers of my investment newsletter, Australian Small-Cap Investigator, telling them now was the time to BUY.
Back in October 2023, I wrote:
‘Bear markets like now can deliver you a huge benefit if you can think truly long term!’
And I suggested they accumulate a handful of stocks run by people with ‘skin in the game’…
In other words, ‘Alpha Gene’ stocks — just like the ones I’ve been showing you today.
That means you would’ve had the chance to make FOUR TIMES your money with just ONE of my recommendations.
Of course, I’m not always right like this.
But I was confident in these stocks, because as I told my subscribers at the time…
‘[These leaders] have every incentive to nurture their business and treat your capital as preciously as theirs.’
These are the stocks to trust during the good times and the hard times…
With high rates, or low rates…
With full employment, or bad job numbers.
You get the idea.
That’s why I’m not worried about Donald Trump’s latest economic blunder either…
Because this ‘Alpha Gene’ phenomenon will far outlast Trump’s second term in office.
As you can see from my track record, I tend to trust my own analysis and experience from my 13 years in the markets…
But trusted sources like Harvard Business Review back me up on this too.
Their research shows that, in general, companies led by people with ‘skin in the game’ tend to invest more aggressively…
Innovate much quicker…
And ultimately, grow their revenues at a much faster pace…
Take the CEO of Sigma Healthcare [ASX:SIG], Mario Verrocchi…
In his own words…
‘[It took] 50 years of toil, 50 years of grind, a bit of blood and sweat and tears’to get the company to the top of the pharmaceutical industry.
And this hard graft is reflected in the company’s stock price…
It’s up 374% in five years, and up more than double in just the last year alone.
When asked if he’s ready to retire, Mario said: ‘I’ll chain myself to my desk.’
Or how about the driving force behind WiseTech Global, billionaire Richard White…
This guy went from writing code in his basement to running one of Australia’s most successful technology companies.
WiseTech’s stock is up 2,994% in under a decade, and up 433% over the last five years.
As White says himself, ‘I am WiseTech. There is no WiseTech without me.’
And then there’s the founder of Pro Medicus, Sam Hupert…
The Australian Financial Review calls him ‘the most understated chief executive on the ASX, running the most understated tech giant on the exchange.’
Pro Medicus’s stock is up 22,582% in the last 15 years…
More than 700% in the last five years…
And they’ve still managed to double in value AGAIN over the past year.
Hupert’s been quietly growing the company for four decades now, and won’t be giving up the reins anytime soon…
All these stories…
All the evidence I’ve shown you today…
All these incredible returns for investors, no matter what the rest of the market or economy is doing…
That’s why I had the confidence to tell my subscribers to buy into these ‘Alpha Gene’ stocks during the bear market, back in 2023…
And it’s also why I’m so confident in the four stocks I want to share with you today.
Let me tell you about each of them now…
If you were to meet the founder of this company, with his baseball cap and handlebar moustache…
You might not guess he’s worth $43 million.
And that’s exactly why I like him.
He’s not some stuck-up MBA graduate…
He’s a humble mechanic who’s built a company that the entire world of high-performance racing depends on.
Every team in F1 — the pinnacle of global motorsports — uses his tech…
And so do teams in NASCAR, MotoGP, IndyCar, Super GT, Supercars — you name it.
So, no surprises his company’s profits have gone one way since it listed on the ASX — UP…
In 2024 alone, they made $140 million in revenue and a $24 million profit — that’s big money.
But he’s just getting started…
He also has a factory in the USA…and can largely dodge Trump’s tariffs.
Basically, he’s setting his company up for its biggest year ever in 2026…
And the sky’s the limit beyond that…
That’s why I reckon the best time to get in alongside him is right now…
BEFORE his next move hits the mainstream news.
If you’re like me and you’re keen to back this F1 superstar…
You’ll find the full details of his company in my special report…
‘4 ASX Alpha Gene Plays for 2025’.
I’ll show you how to download your copy in just a moment.
Inside, you’ll also discover…
The late real estate mogul Sam Zell was known as ‘the grave dancer’.
He would find ‘dead’ assets nobody wanted to touch…
Pick them up for cents on the dollar…
And bring them roaring back to life.
That’s how he amassed his almost US$5 billion fortune.
Well, this next pick is founded by a bloke I call ‘the Aussie grave dancer’...
A mining visionary with a knack for buying up unwanted mine sites and turning them into cash cows.
That’s exactly what he did during the 2014 precious metals bear market.
He headed up a former one-cent-per-share gold miner…
And swooped in to buy three mine sites from a struggling US gold giant.
Not long after, the gold price took off…
And he turned those mines into the foundation of his decade-long business success story.
Today, that company has returned almost 11,000% for his early investors.
Now, this guy is grave dancing again…
Here’s why…
Recently, he got his hands on an abandoned mine in New South Wales…
We’re talking a tier one resource location with $340 million worth of infrastructure ready to go…
All for an initial payment of just $30 million.
In fact, some of the mining equipment was still just sitting there in its original packaging, completely untouched!
Despite the previous owner offloading it for dirt cheap…
Our guy knew there were healthy copper and zinc deposits sitting right there on site…
And he was absolutely bang-on.
In fact, they’ve already lifted the resource estimates of the mine dramatically…
And he’s confident there could still be much more upside yet to come.
The best part is, I’ve seen this ‘resurrection’ story play out before…
In late 2023, Spartan Resources [ASX:SPR] made a huge discovery just north of its old exhausted pit…
Since then, its share price has been up as high as 440%.
I recommended Spartan to my followers back in April 2024, so we captured a decent chunk of that rise.
One of my subscribers, Paul G, emailed to tell me:
‘Just letting you know my average buy price for Spartan was 51.11 cents. I sold all my Spartan holding yesterday at $1.74. A nice profit of 239%.’
This Aussie grave dancer’s current project has yet to see a similar bump, but I believe it’s probably not too far off…
You see, this project has just entered what I call the ‘mining sweet spot’…
That’s when a miner is within about a year before its first cash flow.
In my experience, a stock can often double in value during this period, if all goes to plan.
Of course, I’m not making any guarantees here…
But if I’m backing one mining visionary in 2025…
It’s definitely this guy.
To make sure you don’t miss out on this opportunity, make sure to read the full analysis in my special report, ‘4 ASX Alpha Gene Plays for 2025’.
Alright, let’s have a look at my next pick…
You’ll find this founder out in the harsh Aussie desert, days away from civilisation.
Enduring 50-degree heat…
Hunting for gold.
But he won’t be satisfied with just any old gold discovery…
Because his quest is unbelievably ambitious, if not completely mad.
He’s scouring the Outback for a find that will eclipse the biggest gold mine in the world…
A ‘hypergiant’ deposit that could contain 200 million ounces of gold.
And at a gold price of over US$3,000 per ounce, this find would be worth more than US$600 billion…
And our hypergiant hunter thinks he might have found it.
After four years of preparation, he’s gearing up to do the first-ever diamond-tipped drilling on this ground in 2025…
Right as the gold price is hitting new all-time highs.
Sure, there are no guarantees he’s right.
But if he is…
The potential windfall is so massive, you’d be crazy not to have this stock on your radar.
A few years after that recommendation, Chalice hit a big strike in greenfield land in Western Australia…
Their share price ripped up from 20 cents…
To as high as $10.
That’s a 4,900% rise.
And based on the potential size of this new ‘hypergiant’ find…
This opportunity I’m recommending today could end up being even bigger than Chalice Mining.
As a bonus, I’ve also found a little-known way for us to get in on this play that potentially reduces your downside exposure.
This approach benefits from the roaring bull market going on in Aussie gold stocks right now.
I’ll show you how this play works in detail, inside my special report, ‘4 ASX Alpha Gene Plays for 2025’.
That brings us to the last pick I’d like to share with you…
The founder of my last pick started out with one bobcat digger and 14 grand in his pocket…
And he turned that startup capital into a $1 billion construction empire.
He’s a born and bred Dubbo boy…
And one of the shrewdest businessmen around.
Now, he’s right at the heart of the government's $270 billion ramp-up in infrastructure spending.
He’s spent 20 years buying up quarries to supply the materials Australia needs for the next phase of its massive build-out.
Today, you can ride this multibillion-dollar wave right alongside him for just a few bucks.
You’ll find all the details of this play, and my three other ‘Alpha Gene’ plays…
Including the names, ticker symbols, buy-up-to prices, unique risks, and my full analysis of each company…
Inside my special report, ‘4 ASX Alpha Gene Plays for 2025’.
When you download your copy, you’ll discover…
Each of these stocks has the chance to be the biggest hitter in your portfolio.
And today, you can get your hands on ‘4 ASX Alpha Gene Plays for 2025’ for…
That small cost gives you three months of membership to Australian Small-Cap Investigator and immediate access to this special report.
Australian Small-Cap Investigator is my monthly newsletter where I share my most promising small-cap plays listed on the Australian market.
When you subscribe, you’ll get…
And the best part is, your subscription comes with a 90-day money-back guarantee.
So, if you aren’t absolutely loving everything you’re getting from me, you can let my Melbourne-based customer service team know any time within your first 90 days and we’ll give you a full refund, no questions asked.
It’s not just me you’ll be joining either, but a community of like-minded Aussie investors.
‘I call Callum’s trades “money in the bank” because of the high probability that most of his recommendations will appreciate and often quickly.’
Wel G
‘Very satisfied with Callum’s service, mostly winners. Last year, 40% gains...I’ll take that!’
Steve Floyd
‘My small-caps have remained in profit overall after the first 12–14 months. Thank you for all your recommendations and please keep up the good work.’
Peter F
‘Callum’s service is fantastic, and I recommend it 100%. I have made money on the following: TUA, SPR, and NXL around 30%.’
Paul S
‘Probably the best advice around when it comes to investing in small-caps.’
Moss
I want to help you find killer companies to add to your portfolio, too…
Starting with the four ‘Alpha Gene’ stocks I’ve been sharing with you today…
Plus, three more brand-new small-cap recommendations over the next three months.
But right now, you may be wondering…
It’s simple really…
My MO is finding great companies before most other people catch on to them.
And the small-cap market is stacked with great companies…if you know what to look for.
Remember, certain ‘Alpha Gene’ small-caps made NINE times more money than the ASX Small Ordinaries index over a three-year period…
That’s serious outperformance.
Sure, you definitely have to go in with your head screwed on…
We’re talking about the fastest moving stocks on the ASX here — they can halve just as fast as they can double…
But if you can stomach the ups and downs…
Tuas is a great example.
I recommended this small-cap back in March 2023…
And we cashed out half our holding at the end of last year for a 300% gain.
Peter M, one of my subscribers, wrote to say:
‘Tuas is at an unrealised profit of over 300% after 19 months. I highly recommend it to anyone who is interested in joining the service.’
Subscriber DJS added:
‘Callum’s calls in the small-cap space have been prescient. Most of my positions are in profit (TUAS, SPR > 100% profit). Overall gains for Callum’s recommendations have been remarkable!’
We also had a big win on Nuix [ASX:NXL].
This small-cap shot up 658% in 18 months.
Australian Small-Cap Investigator subscriber Paul Matthews got in on this, saying:
‘400%+ on Nuix. Very happy with that.’
And Wayne, one of my long-time subscribers, emailed to tell me:
‘Extremely happy with your service. Currently holding Nuix, +432% and rising. I have had many others that have done very well. I can highly recommend Callum to you.’
I also recommended…
Of course, we don’t win them all.
Like when we exited 20% below our buy price on Avita Medical [ASX:AVH].
But that’s just part of the game when investing in small-caps.
You have to accept you'll have some losers for the chance at these outsized gains.
And, as I say, as I record this, the open positions in our portfolio are well in the green.
Simply click on the button below.
When you do, you’ll be taken to a secure order form.
Review everything you’re getting when you join me inside Australian Small-Cap Investigator today.
As soon as your order is confirmed, I’ll immediately send you your digital copy of my special report, ‘4 ASX Alpha Gene Plays for 2025’.
You could be placing buy orders on these four stocks within the next half hour, if you want.
Plus, you’re also getting instant access to all the other benefits of Australian Small-Cap Investigator, including my open portfolio recommendations and additional monthly picks…
You can access all of this inside our private members-only website.
And remember, your subscription comes with a 90-day money-back guarantee…so you don’t have to make a decision today.
Don’t worry about Trump’s tariffs…
Falling GDP forecasts…
Unstable bond yields…
Or whether the chair of the RBA has sneezed or not…
All that really matters is finding killer companies before other investors pick up the scent.
And, as I’ve shown you today, the ‘Alpha Gene’ is hands down the best way to find those companies.
I’ve shown you how certain stocks with this ‘gene’ outperformed the rest of the market…
And how some of them went up hundreds, even thousands, of per cent…
Now, you have the chance to add four of these stocks to your portfolio…
For a few bucks each…
Right before they could really start to move.
Go ahead — click the button below now…
Fill out the secure order form on the next page…
And you could be reading your copy of ‘4 ASX Alpha Gene Plays for 2025’ within the next few minutes.
I look forward to welcoming you into our community.
I’m Callum Newman — have a great day.
Sincerely,
Callum Newman,
Editor, Australian Small-Cap Investigator